"Immunization, Passive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
| Descriptor ID |
D007116
|
| MeSH Number(s) |
E02.095.465.425.400.330 E05.478.550.520
|
| Concept/Terms |
Immunization, Passive- Immunization, Passive
- Immunizations, Passive
- Passive Immunization
- Passive Immunizations
Passive Antibody Transfer- Passive Antibody Transfer
- Antibody Transfer, Passive
- Antibody Transfers, Passive
- Passive Antibody Transfers
- Transfer, Passive Antibody
- Transfers, Passive Antibody
- Passive Transfer of Immunity
Immunotherapy, Passive- Immunotherapy, Passive
- Passive Immunotherapy
- Immunotherapies, Passive
- Passive Immunotherapies
Immunoglobulin Therapy- Immunoglobulin Therapy
- Therapy, Immunoglobulin
- Immunoglobulin Therapies
- Therapies, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunization, Passive".
Below are MeSH descriptors whose meaning is more specific than "Immunization, Passive".
This graph shows the total number of publications written about "Immunization, Passive" by people in this website by year, and whether "Immunization, Passive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 0 | 2 | 2 |
| 1996 | 3 | 3 | 6 |
| 1997 | 0 | 1 | 1 |
| 1998 | 4 | 1 | 5 |
| 1999 | 1 | 5 | 6 |
| 2000 | 0 | 3 | 3 |
| 2001 | 2 | 4 | 6 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 3 | 2 | 5 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 3 | 1 | 4 |
| 2016 | 1 | 1 | 2 |
| 2018 | 1 | 1 | 2 |
| 2020 | 0 | 10 | 10 |
| 2021 | 1 | 5 | 6 |
| 2022 | 1 | 10 | 11 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunization, Passive" by people in Profiles.
-
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. JCI Insight. 2024 Mar 14; 9(8).
-
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. Microbiol Spectr. 2024 Jan 11; 12(1):e0328623.
-
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. Transfusion. 2023 09; 63(9):1639-1648.
-
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial. J Infect Dis. 2023 05 29; 227(11):1266-1273.
-
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. Clin Infect Dis. 2023 02 08; 76(3):e477-e486.
-
Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. Nat Biomed Eng. 2022 08; 6(8):992-1003.
-
Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET). J Clin Immunol. 2022 10; 42(7):1545-1552.
-
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern. Blood Adv. 2022 06 28; 6(12):3678-3683.
-
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. J Clin Invest. 2022 05 16; 132(10).
-
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Vaccine. 2022 06 09; 40(26):3655-3663.